Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05438732 · ClinicalTrials.gov registry record · NA
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
A NA study of Age-related Macular Degeneration and Geographic Atrophy, sponsored by VisionCare.
- Recruiting
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 10
- Study locations
NCT05438732: Recruiting NA study of Age-related Macular Degeneration and Geographic Atrophy, sponsored by VisionCare.
NCT05438732 is a NA study of Age-related Macular Degeneration and Geographic Atrophy that is actively recruiting participants, run by VisionCare. The registered enrollment target is 125 participants, below the 1,506-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (92% lower). The trial reports 10 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05438732, a NA study of Age-related Macular Degeneration and Geographic Atrophy, is actively recruiting participants, sponsored by VisionCare.
- RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 10
- Study locations
Study Summary
The objective of this study is to determine the safety and effectiveness of the smaller incision, new generation (SING), implantable miniature telescope (IMT) in patients with moderate-severe central vision loss due to late-stage age-related macular degeneration (AMD).
Primary Outcome
Proportion of study eyes with an improvement of 10 or more ETDRS letters (0.2 logMAR) in either BCDVA or BCNVA at Visit 5 (330 to 420 days post-operatively) compared to Pre-operative Visit
Conditions Studied
Interventions
- DEVICE smaller incision, new generation implantable miniature telescope (SING-IMT)
Study Locations (10)
California
- Loma Linda University - Loma Linda
- Eye Physicians of Long Beach - Long Beach
Florida
- Sarasota Retina Institute - Sarasota
Massachusetts
- Tallman Eye Associates - Lawrence
Michigan
- Oakland Ophthalmic Surgery - Birmingham
Nebraska
- Vance Thompson Vision - Omaha
New Jersey
- Atlantic Eye Physicians - Eatontown
North Carolina
- Western Carolina Retinal Associates - Asheville
Ohio
- Cleveland Clinic | Cole Eye Institute - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2022-06-16 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT05438732 shows while recruiting
NCT05438732 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 1,506-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 1 intervention - of which smaller incision, new generation implantable miniature telescope (SING-IMT) is the first listed.
NCT05438732 lists 10 locations in 9 states (California, Florida, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT05438732 about?
NCT05438732 is a clinical study titled "Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD". The objective of this study is to determine the safety and effectiveness of the smaller incision, new generation (SING), implantable miniature telescope (IMT) in patients with moderate-severe central vision loss due to late-stage age-related macular degeneration (AMD).
What is the current status of trial NCT05438732?
This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2022-06-16. Estimated completion is 2025-12.
What conditions does trial NCT05438732 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration, Geographic Atrophy.
What interventions are being tested in trial NCT05438732?
The interventions under investigation include: smaller incision, new generation implantable miniature telescope (SING-IMT) (DEVICE).
Who is sponsoring clinical trial NCT05438732?
This trial is sponsored by VisionCare, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05438732 being conducted?
This trial has 10 study locations across California, Florida, Massachusetts, Michigan, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05438732's enrollment target sits among peer trials
125 26th of 74 higher than 48 of 74 other Age-related Macular Degeneration trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Age-related Macular Degeneration trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Visual Remapping to Aid Reading With Field Loss
RECRUITING · NA
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
-
Lutein, Zeaxathin, and Fish Oil Supplementation
RECRUITING · NA
-
Stem Cell Ophthalmology Treatment Study II
RECRUITING · NA
-
AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI